Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001415889-25-007071

Options or other derivatives

  • President and CEO acquired 800,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Mack David Henry President and CEO 2025-03-03 Grant or award · Employee Stock Option (right to buy) +800,000 800,000 D: show line 1 in the form
Loading xslF345X05/form4-03052025_110346.xml…